VRTX Cash Flow Statement
Vertex Pharmaceuticals Inc - Operating, Investing & Free Cash Flow Analysis
Operating Cash Flow
$3.63B
Free Cash Flow
$4.07B
FCF per Share
-
3.34% yield
CapEx
$437.60M
Operating Activities
Cash generated from core business operations
Primary cash generation
Investing Activities
Cash used for investments and capital expenditures
Total investing activities
Financing Activities
Cash from financing activities including debt, equity, and dividends
Total financing activities
Free Cash Flow (FCF) Calculation
Cash Flow Trends (Annual)
| Period | Operating CF | Investing CF | Financing CF | Free CF |
|---|---|---|---|---|
| 2025-12-31 | $3.63B | ($945.40M) | ($2.26B) | $4.07B |
| 2024-12-31 | ($492.60M) | ($3.77B) | ($1.49B) | - |
| 2024-12-31 | ($492.60M) | ($3.77B) | ($1.49B) | ($194.90M) |
| 2023-12-31 | $3.54B | ($3.14B) | ($562.20M) | - |
| 2023-12-31 | $3.54B | ($3.14B) | ($562.20M) | $3.74B |
View Complete Financial Analysis
Full income statements, balance sheets, and detailed cash flow analysis
Open Full AnalysisFrequently Asked Questions
What is VRTX free cash flow?
VRTX's most recent free cash flow (FCF) is $4.07B. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is available for dividends, buybacks, or debt reduction.
What is VRTX operating cash flow?
VRTX generated $3.63B in operating cash flow in the most recent period. Operating cash flow shows the cash generated from core business operations.
What is VRTX FCF per share?
FCF per share can be calculated by dividing free cash flow by shares outstanding.
Is VRTX cash flow growing?
VRTX's operating cash flow grew by 837.2% year-over-year.
What is VRTX FCF yield?
VRTX has a free cash flow yield of 3.34%, calculated as free cash flow divided by market capitalization. A higher FCF yield may indicate better value.
What is VRTX capital expenditure?
VRTX spent $437.60M on capital expenditures (CapEx) in the most recent period. CapEx represents investments in property, plant, and equipment.